Temozolomide suppresses MYC via activation of TAp63 to inhibit progression of human glioblastoma.
Yamaki T, Suenaga Y, Iuchi T, Alagu J, Takatori A, Itami M, Araki A, Ohira M, Inoue M, Kageyama H, Yokoi S, Saeki N, Nakagawara A.
Yamaki T, et al. Among authors: suenaga y.
Sci Rep. 2013;3:1160. doi: 10.1038/srep01160. Epub 2013 Jan 29.
Sci Rep. 2013.
PMID: 23362460
Free PMC article.